Epidermolysis Bullosa: Pediatric Perspectives.
Hon KL, Chu S, Leung AKC.
Curr Pediatr Rev. 2022;18(3):182-190. doi: 10.2174/1573396317666210525161252.
Herpes simplex virus gene therapy for dystrophic epidermolysis bullosa (DEB).
Epstein AL, Haag-Molkenteller C.
Cell. 2023 Aug 17;186(17):3523-3523.e1. doi: 10.1016/j.cell.2023.07.031.
In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial.
Gurevich I, Agarwal P, Zhang P, Dolorito JA, Oliver S, Liu H, Reitze N, Sarma N, Bagci IS, Sridhar K, Kakarla V, Yenamandra VK, O'Malley M, Prisco M, Tufa SF, Keene DR, South AP, Krishnan SM, Marinkovich MP.
Nat Med. 2022 Apr;28(4):780-788. doi: 10.1038/s41591-022-01737-y. Epub 2022 Mar 28.
Dystrophic Epidermolysis Bullosa Inversa - Case Report and Review of the Literature.
Merzel Šabović EK, Luzar B, Wechtersbach K, Dolenc-Voljč M.
Acta Dermatovenerol Croat. 2022 Nov;30(3):151-156.
Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa.
Paller AS, Guide SV, Ayala D, Gonzalez ME, Lucky AW, Bagci IS, Marinkovich MP.
J Dermatolog Treat. 2024 Dec;35(1):2350232. doi: 10.1080/09546634.2024.2350232. Epub 2024 May 9.
Dystrophic Epidermolysis Bullosa.
Yadav RS, Jayswal A, Shrestha S, Gupta SK, Paudel U.
JNMA J Nepal Med Assoc. 2018 Sep-Oct;56(213):879-882. doi: 10.31729/jnma.3791.
Dystrophic epidermolysis bullosa - From biochemistry to interventions.
Nyström A.
Matrix Biol. 2025 Apr;136:111-126. doi: 10.1016/j.matbio.2025.02.001. Epub 2025 Feb 6.
Dystrophic epidermolysis bullosa: from disease biology to biologic therapy.
Samuelov L.
Br J Dermatol. 2024 Jul 16;191(2):159-160. doi: 10.1093/bjd/ljae182.
Dystrophic epidermolysis bullosa.
Das BB, Sahoo S.
J Perinatol. 2004 Jan;24(1):41-7. doi: 10.1038/sj.jp.7211019.
Recessive Dystrophic Epidermolysis Bullosa: Advances in the Laboratory Leading to New Therapies.
Woodley DT, Chen M.
J Invest Dermatol. 2015 Jul;135(7):1705-1707. doi: 10.1038/jid.2015.149.
